Cervical Cancer: The Indian Government has announced all girls above the age of 14 would receive a free dosage of Gardasil, a quadrivalent Human papillomavirus (HPV) single-shot vaccine, to stay protected against HPV types 16 and 18 that can result in cervical cancer, as well as type 6 and 11.
The vaccination program from February 28, 2026 would be voluntary and free so that every girl in the country could access equitable access of the HPV vaccine.
HPV Vaccination For Cervical Cancer-Benefits & Why To Administer?
The Indian Government has announced this decision in conformity with the WHO’s Strategic Advisory Group of Experts on Immunization.
Girls aged 14 years and above would receive the vaccine at the designated vaccination centres during the campaign’s first 90 days. After this period, girls aged 14 years and above would be able to book a vaccination slot of their choice using the U-win portal and get themselves vaccinated at their nearest health & wellness centre.
DON'T MISS
Health officials remarked that 1.15 crore girls in the country who turn 14 would be eligible for the Human papillomavirus (HPV) single-shot vaccine.
GAVI vaccine alliance would offer 2.6 crore doses to India, out of which 1 crore have already reached the country. The remaining would arrive through this year and next.
Studies in England and Sweden have demonstrated that early vaccination in teenage years could help significantly reduce the risk of cervical cancer in girls by over 85 percent at age 30.
What Is Cervical Cancer?
Cervical Cancer happens when the cervix cells start to alter to precancerous cells. This health condition is usually not characterized by symptoms until it starts spreading quickly. Therefore, HPV vaccination and a Pap smear (a form of regular cervical cancer screening) are recommended.
Prashant Bhushan Raises Serious Concerns
In another development, Prashant Bhushan has raised serious concerns over the proposed use of Gardasil.
In rare cases, the use of Gardasil is associated with fainting in approximately 15 percent of teen girls post-vaccination, which is primarily from needle anxiety. Allergic reactions such as anaphylaxis or hives may strike 1 in 1 million doses, which is treatable with epinephrine.
